IRLAB's CEO Intends to Step Down During the First Quarter of 2027

GOTHENBURG, SE / ACCESS Newswire / September 3, 2026 / IRLAB Therapeutics AB (STO:IRLAB-A)(FRA:6IRA), a company discovering and developing novel treatments for Parkinson's disease, announces today that Kristina Torfgård has informed the Board of …